Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohort

Fig. 2

Changes of methylation with increasing severity of cancer phenotypes in the TCGA cohort. A Changes in methylation at the hypo-methylated DMPs from Stage I to Stage IV of cancer in the TCGA cohort. B Changes in methylation at the hyper-methylated DMPs from mild to severe stages of cancer in the TCGA cohort. C Higher expression of hypo-methylated gDMs observed from Stage I to Stage IV cancer samples. D Changes in expression of hyper-methylated gDMs across stages of TCGA cohort. E Survival plots showing differences in disease prognosis among the TCGA cohort patients with high and low expressions of the gDMs

Back to article page